National Health Act 1953 Declaration under subsection 85(2AA) (No. PB 3 of 1990) (Cth)

COMMONWEALTH OF AUSTRALIA

NATIONAL HEALTH ACT 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUB-SECTION 85(2AA)

No. PB3 of 1990

I, MARGARET NONA FORD, Principal Advisor, Health Care Access Division, Department of Community Services and Health and Delegate of the Minister of State for Community Services and Health, pursuant to sub-section 85(2AA) of the National Health Act 1953, hereby make the following Declaration:

1.         This Declaration shall come into operation on 1 April 1990.

2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Ambenonium Chloride

Lauryl Dimethylamine Oxide with Octoxinol

Mithramycin

Neostigmine Methylsulphate

Papaveretum

Papaveretum with Hyoscine Hydrobromide

Phytomenadione

Dated this sixteenth day of March 1990.

MARGARET FORD

PRINCIPAL ADVISOR

HEALTH CARE ACCESS DIVISION

DEPARTMENT OF COMMUNITY SERVICES AND HEALTH

DELEGATE OF THE MINISTER OF STATE FOR COMMUNITY SERVICES AND HEALTH